Bharat Biotech, Serum Institute to begin trials of intranasal COVID vaccines: Dr Harsh Vardhan Ruchika Sharma19 Oct 2020 1:00 PM ISTNew Delhi: Serum Institute of India and Bharat Biotech are expected to pursue late stage clinical trials of intranasal Covid-19 vaccines in the coming...
COVID Vaccine Distribution: Govt disagrees with Rs 80,000 Crore figure given by Serum Institute Ruchika Sharma1 Oct 2020 9:45 AM ISTNew Delhi: The government on Tuesday said it does not agree with the calculation that Rs 80,000 crore is needed for distribution of COVID-19 vaccine...
Serum Institute to develop 200 million doses of COVID vaccine MD Bureau30 Sept 2020 11:45 AM ISTThe vaccines will have a ceiling price of US$3 per dose, a price enabled by investments made by partners such as the Coalition for Epidemic...
Serum Institute to develop US biotech firm Codagenix nasal COVID vaccine Ruchika Sharma23 Sept 2020 12:00 PM ISTNew Delhi: Codagenix Inc said on Tuesday Serum Institute of India has started manufacturing the U.S. biotech firm's potential Covid-19 vaccine and it...
Serum Institute gets DCGI nod to restart Oxford Vaccine trial with certain conditions Ruchika Sharma17 Sept 2020 11:37 AM ISTDSMB, India, also has recommended to continue the study and enroll the remaining participants in the clinical trial as per protocol subject to certain...
Serum Institute, Novavax ink pact for producing over 2 billion vaccine doses Ruchika Sharma16 Sept 2020 1:17 PM ISTNVX-CoV2373 is a stable, prefusion protein made using Novavax' recombinant protein nanoparticle technology and includes Novavax' proprietary Matrix-M...
Serum Institute halts COVID vaccine trials in India MD Bureau11 Sept 2020 10:00 AM ISTIn a statement, the Serum Institute of India said: "We are reviewing the situation and pausing India trials till AstraZeneca restarts the trials. We...
Suspension of Covishield trials in UK spells havoc for Astrazeneca and Serum Institute of India Ruchika Sharma10 Sept 2020 1:58 PM ISTNew Delhi: Owing to a suspected severe adverse reaction on a participant after being administered a booster dose of Covishield, the Drugs Controller...
Oxford COVID vaccine phase 2 trial to begin in PGI Chandigarh MD Bureau29 Aug 2020 9:30 AM ISTPGI Chandigarh has received approval from its internal ethical committee and is awaiting the signing of the tripartite agreement between the Indian...
Oxford COVID vaccine Phase 2 trial begins at Pune hospital MD Bureau27 Aug 2020 10:00 AM ISTNew Delhi : The Phase II clinical trial of the Oxford Covid-19 vaccine, Covishield, began on Wednesday. The first dose was given to two...
Serum Institute shuns reports of commercializing Covishield, says will sell only after successful trial MD Bureau24 Aug 2020 1:30 PM IST"Covishield will be commercialised once the trials are proven successful and all the requisite regulatory approvals are in place", it added.
Govt panel meets COVID vaccine makers including Serum Institute, Zydus Cadila, others Ruchika Sharma18 Aug 2020 1:00 PM ISTNew Delhi: The national expert group on vaccine administration for Covid-19 met representatives of leading domestic manufactures, including Serum...
